EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension

Prangthip Charoenpong, Nicole M Hall, Courtney M Keller, Anil Kumar Ram, Kevin S Murnane, Nicholas E Goeders, Navneet Kaur Dhillon, Robert E Walter

CHEST · 2024

DOI: 10.1016/j.chest.2024.01.014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CHEST, 2024. Verfasst von Prangthip Charoenpong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Louisiana State University Health Sciences Center at Shreveport, S…. Hauptthemen laut MEDLINE: Methamphetamine, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

TOPIC IMPORTANCE: The global surge in methamphetamine use is a critical public health concern, particularly due to its robust correlation with methamphetamine-associated pulmonary arterial hypertension (MA-PAH). This association raises urgent alarms about the potential escalation of MA-PAH incidence, posing a significant and imminent challenge to global public health. REVIEW FINDINGS: This comprehensive review meticulously explores MA-PAH, offering insights into its epidemiology, pathophysiology, clinical presentation, diagnostic intricacies, and management strategies. The pathogenesis, yet to be fully described, involves complex molecular interactions, including alterations in serotonin signaling, reduced activity of carboxylesterase 1, oxidative stress, and dysregulation of pulmonary vasoconstrictors and vasodilators. These processes culminate in the structural remodeling of the pulmonary vasculature, resulting in pulmonary arterial hypertension. MA-PAH exhibits a more severe clinical profile in functional class and hemodynamics compared with idiopathic pulmonary arterial hypertension. Management involves a multifaceted approach, integrating pulmonary vasodilators, cessation of methamphetamine use, and implementing social and rehabilitation programs. These measures aim to enhance patient outcomes and detect potential relapses for timely intervention. SUMMARY: This review consolidates our understanding of MA-PAH, pinpointing knowledge gaps for future studies. Addressing these gaps is crucial for advancing diagnostic accuracy, unraveling mechanisms, and optimizing treatment for MA-PAH, thereby addressing the evolving landscape of this complex health concern.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethamphetaminePulmonary Arterial HypertensionHumansAmphetamine-Related DisordersCentral Nervous System StimulantsHypertension, Pulmonary

Stichwörter der Autor:innen

estrogen paradoxmethamphetaminemethamphetamine-associated pulmonary arterial hypertensionpulmonary arterial hypertensionpulmonary hypertension

Substanzen

MethamphetamineCentral Nervous System Stimulants

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA; Center for Cardiovascular Diseases and Sciences, Louisi…
  • Center for Cardiovascular Diseases and Sciences, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA; Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at…
  • Louisiana Addiction Research Center, Louisiana State University Health Sciences Center at Shreveport, Shreveport, LA; Department of Pharmacology, Toxicology & Neuroscience, Louisiana State University Health Sciences Cen…
  • Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Internal Medicine, University of Kansas Medical Center, Kansas City, KS.

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • NIH

Zitieren

APA

Charoenpong, P., Hall, N. M., Keller, C. M., Ram, A. K., Murnane, K. S., Goeders, N. E., Dhillon, N. K., & Walter, R. E. (2024). Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension. CHEST. https://doi.org/10.1016/j.chest.2024.01.014

Vancouver

Charoenpong P, Hall NM, Keller CM, Ram AK, Murnane KS, Goeders NE, et al. Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension. CHEST. 2024. doi:10.1016/j.chest.2024.01.014

BibTeX
@article{Charoenpong2024,
  author = {Charoenpong, Prangthip and Hall, Nicole M and Keller, Courtney M and Ram, Anil Kumar and Murnane, Kevin S and Goeders, Nicholas E and Dhillon, Navneet Kaur and Walter, Robert E},
  title = {Overview of Methamphetamine-Associated Pulmonary Arterial Hypertension},
  journal = {CHEST},
  year = {2024},
  doi = {10.1016/j.chest.2024.01.014}
}
Kostenlos starten →